PuSH - Publication Server of Helmholtz Zentrum München

16 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Justice, A.E.* et al.: Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution. Nat. Genet. 51, 452–469 (2019)
Klarin, D.* et al.: Genetics of blood lipids among similar to 300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514-1523 (2018)
Mahajan, A.* et al.: Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559-571 (2018)
Liu, D.J.* et al.: Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758-1766 (2017)
Lu, X.* et al.: Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49, 1722–1730 (2017)
Webb, T.R.* et al.: Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease. J. Am. Coll. Cardiol. 69, 823-836 (2017)
Scott, R.A.* et al.: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Sci. Transl. Med. 8:341ra76 (2016)
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016)
Stitziel, N.O.* et al.: Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (vol 374, pg 1134, 2016). N. Engl. J. Med. 374, 1898-1898 (2016)
Zanoni, P.* et al.: Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 351, 1166-1671 (2016)
Jansen, H.* et al.: Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. Atherosclerosis 241, 419-426 (2015)
TG and HDL Working Group (Crosby, J.R.* ; Peloso, G.M.* ; Auer, P.L.* ; Peters, A. ; Reiner, A.P.* ; Boerwinkle, E.* ; Kathiresan, S.*): Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014)
Stitziel, N.O.* et al.: Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371, 2072-2082 (2014)
Global Lipids Genetics Consortium et al.: Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013)
Do, R.* et al.: Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345-1352 (2013)
Teslovich, T.M.* et al.: Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010)